Electronic-Nutrition-Optimizer for Personalized Prevention (eNO)

This study aims to develop and validate a tool for immediate nutrition assessment and to test its user feasibility in routine clinical practice for health promotion.

Study Overview

• Status: Completed
• Conditions: Cardiovascular Diseases; Hypertension; Diabetes; Dementia; Frailty
• Intervention / Treatment: Device: eNutrition Optimizer

Detailed Description

Small changes in diet have been shown to have an important impact on health and the risk of age-related chronic diseases, such as cardiovascular disease, diabetes, frailty and dementia. However, this knowledge has not yet been implemented into routine clinical practice, because practical tools that allow a comprehensive nutrition assessment in the clinical care setting are missing. In addition, doctors are generally not educated in giving nutritional advice to patients. In this pilot project, we aim to push forward and enable the potential of nutrition as a core primary prevention strategy for people at risk of developing chronic diseases. This will be achieved by using, as a stepping stone, the electronic 216-food-item food frequency questionnaire which was developed for the European DO-HEALTH study and was tested in over 2000 adults. The investigators want to extend this tool to not only capture the personal dietary intake, but also to produce an immediate report, comparing the personal diet to the Mediterranean and MIND diet patterns and providing a patient's intake of protein and other nutrients. The report will additionally indicate the patient's diet-related, personalized risks of cardio-vascular disease, diabetes, frailty and cognitive decline, and recommend dietary changes to reduce these risks.

• Study Type: Interventional
• Enrollment (Actual): 88
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Switzerland
  • ZH
    • Zurich, ZH, Switzerland, 8037
      • Centre on Aging and Mobility, University of Zurich

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 50 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: Yes

Description

Inclusion Criteria:

1. Stable inpatients from the Department of heart surgery, or Center for senior trauma patient at the university hospital Zurich (inpatient group)
2. Ambulatory volunteers who can visit the center for aging and mobility (CAM) independently ("outpatients" group)
3. ≥50 years

Exclusion Criteria:

1. If already involved in another ongoing interventional clinical trial, except an interaction with this intervention can be excluded
2. People with an impaired short-term memory (MMSE <24)
3. Patients following a specific diet recommended by a medical professional, due to diseases such as diabetes, chronic diseases of the gastrointestinal tract, severe kidney disease, or patients allergic to the main components of the Mediterranean diet/MINDdiet (olive oil, nuts)
4. Outpatients: HbA1C ≥6.5% Inpatients: HbA1C ≥6.5% or diagnosed diabetes mellitus if HbA1C is not available in KISIM
5. BMI > 30 kg/m2
6. Individuals per se not willing to change diet
7. Instable clinical conditions (e.g. acute infection) at enrolment
8. Patients with active cancer (except non-melanoma skin cancer) or current cancer treatment or any other advanced severe disease
9. Living in a nursing home and/or receiving prepared meals (i.e. usually not eating home cooked meals)
10. Inability to read and or speak German necessary to understand the instructions

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Other
• Allocation: Non-Randomized
• Interventional Model: Crossover Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Outpatient Group; After signing the informed consent, outpatients will be invited for a clinical baseline visit at the Center on Aging and Mobility (CAM), where they will complete the dietary assessment with the eNutrition optimizer at the CAM guided by the study physicians, who will also interpret the immediate results and recommendations produced by the tool to the study participant. For validating the eNutrition-Optimizer tool, participants will be asked to report their dietary intake in the past 24h during a "24-h diet recall phone call" conducted by a trained interviewer on random days (weekday and weekend), so the participant cannot prepare or alter their habits. This 24h diet recall phone calls will be performed 4 times during the second half of the follow-up (month 4 to 6). In addition participants will complete the System Usability Scale at baseline and the subjective effectiveness questionnaire at month 6.	Device: eNutrition Optimizer; The eNutrition optimizer is based on the electronic food frequency questionnaire (FFQ) used in the multicentre randomized controlled trail DO-HEALTH [56] developed by the CAM. The FFQ is split up in sections of 33 food groups and contains 216 items. It asks the user on the relative frequency of consumption of the different foods showing a picture of the food in the portion size of interest. Within the eNutrition Optimizer, the FFQ will be extended to create an output of the user's adherence to the Mediterranean diet, the MIND diet and the adherence with the current dietary recommendations for micro- and macronutrients provided by the Swiss Society for Nutrition and the DACH-references, compare it to the DO-HEALTH population and give recommendations on how to improve the score.
Active Comparator: Inpatient Group; After signing the informed consent, inpatients (Senior trauma center/heart surgery) will do the dietary assessment with the eNutrition optimizer with supervision of a trained study physician to assess user feasibility in the inpatient setting. In addition they will have a follow-up phone call at month 3 to 6 to assess the subjective effectiveness of the eNO.	Device: eNutrition Optimizer; The eNutrition optimizer is based on the electronic food frequency questionnaire (FFQ) used in the multicentre randomized controlled trail DO-HEALTH [56] developed by the CAM. The FFQ is split up in sections of 33 food groups and contains 216 items. It asks the user on the relative frequency of consumption of the different foods showing a picture of the food in the portion size of interest. Within the eNutrition Optimizer, the FFQ will be extended to create an output of the user's adherence to the Mediterranean diet, the MIND diet and the adherence with the current dietary recommendations for micro- and macronutrients provided by the Swiss Society for Nutrition and the DACH-references, compare it to the DO-HEALTH population and give recommendations on how to improve the score.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Perception questionnaire using system usability scale	Feasibility Study (in- and outpatient group) Scale from 1 to 5, indicating 1 "not true", 5 "very true"	Baseline
Subjective effectiveness questionnaire of eNutrition Optimizer	Feasibility Study (in- and outpatient group) Scale from 1 to 5, indicating 1 "not true", 5 "very true"	month 3 to 6

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
24h diet recalls	Validation Study (outpatient group)	month 4 to 6
blood marker Non-HDL cholesterol (mmol/l)	Validation Study (outpatient group)	6 months
blood marker HDL cholesterol (mmol/l)	Validation Study (outpatient group)	6 months
blood marker Triglycerides (mmol/l)	Validation Study (outpatient group)	6 months
blood marker HbA1C (%)	Validation Study (outpatient group)	6 months
blood marker Fasting glucose (mmol/l)	Validation Study (outpatient group)	6 months
blood marker Vitamin B12 (ng/l)	Validation Study (outpatient group)	6 months
blood marker Folate (µg/l)	Validation Study (outpatient group)	6 months
blood marker Iron (µmol/l)	Validation Study (outpatient group)	6 months
blood marker Transferrin (µmol/l)	Validation Study (outpatient group)	6 months
blood marker Soluble transferrin receptor (mg/l)	Validation Study (outpatient group)	6 months
blood marker Ferritin (µg/l)	Validation Study (outpatient group)	6 months
blood marker high sensitive-CRP (mg/l)	Validation Study (outpatient group)	6 months
blood marker Interleukin-6 (pg/ml)	Validation Study (outpatient group)	6 months
Dietary patterns assessed with the eNutrition Optimizer (based on a food frequency questionnaire), MIND diet score ranging from 0 to 15 with 0=worst, 15=best ; Med Diet score ranging from 0 to 55 with 0=worst, 15=best	Change in diet (outpatient group)	6 months
BMI	Change in diet (outpatient group) and safety (outpatient group)	6 months
waist-to-hip ratio	Change in diet (outpatient group) and safety (outpatient group)	6 months
systolic and diastolic blood pressure	Change in diet (outpatient group)	6 months

Collaborators and Investigators

• Sponsor: Heike Bischoff-Ferrari
• Investigators: Principal Investigator: Heike Bischoff-Ferrari, MD,DrPH, Center on Aging and Monbility, University of Zurich

Study record dates

Study Major Dates

• Study Start (Actual): November 11, 2021
• Primary Completion (Actual): May 23, 2024
• Study Completion (Actual): May 23, 2024

Study Registration Dates

• First Submitted: April 1, 2021
• First Submitted That Met QC Criteria: April 27, 2021
• First Posted (Actual): April 29, 2021

Study Record Updates

• Last Update Posted (Actual): August 7, 2024
• Last Update Submitted That Met QC Criteria: August 6, 2024
• Last Verified: August 1, 2024

More Information

Terms related to this study

• Keywords: Mediterranean Diet; Healthy Aging; MIND Diet
• Additional Relevant MeSH Terms: Pathologic Processes; Cardiovascular Diseases; Frailty
• Other Study ID Numbers: 2019-02379

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No